Cervical cancer is a type of cancer that develops in the cervix, the lower part
of the uterus that connects to the vagina. It is primarily caused by the human papillomavirus (HPV), a common sexually transmitted infection.
Understanding the causes, risk factors, symptoms, diagnosis, and treatment
options for cervical cancer is crucial for early detection and effective management.
Infection with certain strains of HPV, particularly HPV types 16 and 18, is the
primary cause of cervical cancer. HPV is transmitted through sexual contact and can lead to abnormal changes in the cells of the cervix, increasing the risk of cancer.
Smoking is a significant risk factor for cervical cancer, as it weakens the
immune system and makes it more difficult for the body to fight off HPV
infection.
Having a weakened immune system due to conditions such as HIV/AIDS or undergoing immunosuppressive therapy increases the risk of cervical
cancer.
Engaging in sexual activity at an early age and having multiple sexual
partners increases the risk of HPV infection and subsequent development
of cervical cancer.
The most common symptom of cervical cancer is abnormal vaginal
bleeding, including bleeding between periods, after intercourse, or after
menopause.
Pelvic pain or discomfort, particularly during intercourse or during pelvic
exams, may occur in some cases of cervical cancer.
Unusual vaginal discharge that may be watery, bloody, or have a foul odor can be a sign of cervical cancer.
A Pap smear, also known as a Pap test, is a screening test used to detect
abnormal cells in the cervix. It involves collecting cells from the cervix and
examining them under a microscope for signs of cancer or precancerous
changes.
The HPV DNA test detects the presence of high-risk HPV strains in cervical
cells, indicating an increased risk of cervical cancer.
A colposcopy is a procedure used to examine the cervix, vagina, and vulva for signs of abnormality using a special magnifying instrument called a colposcope.
If abnormal cells are detected during a Pap smear or colposcopy, a biopsy may be performed to remove a small sample of tissue from the cervix for further examination under a microscope.
A specialized surgical technique used to remove the cervix, uterus, and surrounding tissues, including the parametrium and
lymph nodes, to ensure complete removal of cancerous tissue.
Robotic-assisted surgery offers enhanced precision and shorter recovery times compared to traditional open surgery.
Traditional open surgery may be performed in cases where robotic surgery is not feasible or appropriate.
Chemotherapy drugs are used to kill cancer cells or stop their growth and may be administered orally or intravenously.
Radiation therapy uses high-energy rays to destroy cancer cells and may be used alone or in combination with surgery for treating cervical cancer.
Robotic surgery for cervical cancer offers several advantages, including enhanced precision, smaller incisions, reduced blood loss, shorter hospital stays, and faster recovery times compared to traditional open surgery.
Sentinel lymph node biopsy (SLNB) is a minimally invasive procedure used to assess whether cancer has spread to the lymph nodes near the cervix. It helps guide treatment decisions and may spare some patients from unnecessary lymph node dissection.
Total mesometrial resection is a specialized surgical technique used to remove the cervix, uterus, and surrounding tissues, including the parametrium and lymph nodes, to ensure complete removal of cancerous tissue and reduce the risk of cancer recurrence.
While robotic surgery offers several advantages, traditional open surgery may still be performed in cases where robotic surgery is not feasible or appropriate. Open surgery involves making a larger incision in the abdomen to access the cervix and surrounding tissues for removal.
HPV vaccination involves administering vaccines that protect against certain strains of HPV, particularly types 16 and 18, which are responsible for the majority of cervical cancer cases. These vaccines are highly effective in preventing HPV infection and subsequent development of cervical cancer.
HPV vaccination significantly reduces the risk of HPV infection, thus preventing the development of cervical cancer.
HPV vaccines have been shown to reduce the incidence of
precancerous lesions of the cervix, which are early signs of cervical cancer.
In addition to cervical cancer, HPV vaccination also protects against other HPV-related cancers, including anal, vaginal, vulvar, and oropharyngeal cancers.
High vaccination rates in the population contribute to herd immunity, reducing the overall prevalence of HPV infection and benefiting unvaccinated individuals as well.
HPV vaccination is recommended for both males and females starting at the age of 11 or 12. Vaccination can be administered as early as age 9.
Catch-up vaccination is recommended for individuals who were not vaccinated during adolescence. It is typically offered up to age 26 for females and age 21 for males.
HPV vaccination has made significant strides in cervical cancer prevention since its introduction. Studies have shown a substantial decrease in HPV infection rates and cervical precancerous lesions in vaccinated populations. Continued efforts to improve vaccination coverage rates are essential for maximizing its impact on cervical cancer prevention.
Regular screening for cervical cancer involves performing Pap smears and HPV testing to detect abnormal changes in the cervix early, before they progress to cervical cancer. Screening allows for prompt diagnosis and treatment of precancerous lesions, reducing the risk of cervical cancer development.
Regular screening enables the early detection of precancerous changes in the cervix, allowing for timely intervention and prevention of cervical cancer.
Studies have shown that regular cervical cancer screening
significantly reduces the incidence of invasive cervical cancer by detecting and treating precancerous lesions.
Early detection through regular screening leads to better
treatment outcomes and higher survival rates among women diagnosed with cervical cancer.
Pap smears are recommended every three years for women aged 21 to 65. Women aged 30 to 65 have the option of combining Pap smears with HPV testing every five years.
HPV testing is recommended as a primary screening method for women aged 30 to 65, either alone or in combination with Pap smears.
Regular screening has been instrumental in reducing cervical cancer incidence and mortality rates in countries with organized screening programs. However, disparities in screening access and utilization persist, highlighting the importance of targeted efforts to improve screening coverage among underserved populations.
Maintaining a healthy diet rich in fruits, vegetables, whole grains, and lean proteins can help support overall health and reduce the risk of cervical cancer.
In conclusion, cervical cancer is a preventable and treatable disease when detected early through regular screening and managed with appropriate treatment options such as surgery, radiation therapy, and chemotherapy. Understanding the advantages of robotic surgery and the role of total mesometrial resection and sentinel lymph node biopsy is essential for healthcare providers and patients in optimizing treatment outcomes and improving quality of life.
Cervical cancer treatment in Hyderabad involves a variety of methods tailored to the individual patient’s condition. This type of gynaecological cancer originates in the cells of the cervix, which is the lower part of the uterus. Cervical cancer does not show symptoms in the initial or precancerous stage; therefore, early detection and comprehensive management are essential for effective management. Consulting Dr. Pavan Kumar Jonnada, the best surgical oncologist in Hyderabad, is an optimal choice if you’re looking for the best cervical cancer treatment in Hyderabad.
There are various treatment options for the best cervical cancer surgery in Hyderabad, but robotic cervical cancer surgery in Hyderabad can offer minimally invasive procedures with a faster recovery time and reduced risk of complications.
Dr. Pavan Kumar Jonnada is the best surgical oncologist in Hyderabad, offering a comprehensive range of advanced treatment options. He is known for his expertise in the treatment of gynaecological cancers. Dr. Pavan is committed to providing exceptional care by utilising the latest advancements and a patient-centric approach.
For those who are seeking the best cervical cancer treatment in Hyderabad, Dr. Pavan Kumar Jonnada is an exceptional choice. He is renowned as the best surgical oncologist in Hyderabad, with years of experience in robotic cancer surgery. He focuses on providing personalised treatment and exceptional care to each patient and also ensures the highest quality outcomes.
Want to get the best cervical cancer treatment in Hyderabad? Schedule a consultation with Dr. Pavan Kumar Jonnada to explore your treatment options.
Vansh Clinics & Diagnostics,
212, Kokapet Terminal, Gandipet Road,
Kokapet, Hyderabad
Hitech City, Hyderabad